Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,314
Closed -$324K 1398
2024
Q2
$324K Sell
11,314
-383
-3% -$11.5K ﹤0.01% 1033
2024
Q1
$446K Sell
11,697
-20
-0.2% -$756 ﹤0.01% 977
2023
Q4
$436K Buy
11,717
+88
+0.8% +$2.96K 0.01% 980
2023
Q3
$396K Buy
11,629
+399
+4% +$15.1K 0.01% 970
2023
Q2
$442K Sell
11,230
-486
-4% -$17.5K 0.01% 941
2023
Q1
$376K Buy
11,716
+65
+0.6% +$2.15K 0.01% 987
2022
Q4
$363K Buy
11,651
+57
+0.5% +$2.06K 0.01% 993
2022
Q3
$430K Buy
11,594
+401
+4% +$15K 0.01% 896
2022
Q2
$325K Buy
11,193
+1,101
+11% +$39.4K 0.01% 990
2022
Q1
$519K Buy
10,092
+54
+0.5% +$2.31K 0.01% 882
2021
Q4
$505K Buy
10,038
+69
+0.7% +$3.86K 0.01% 895
2021
Q3
$558K Buy
9,969
+2,678
+37% +$148K 0.01% 837
2021
Q2
$430K Buy
+7,291
New +$410K 0.01% 978

Other funds holding PGNY

Xponance's PGNY Position: Q3 2024 in Review

Xponance sold out of Progyny (PGNY) in Q3 2024, closing a stake of 11,314 shares — an estimated $324K sold.

Xponance first reported a position in PGNY in Q2 2021 and held it in 13 quarters. The position peaked at $558K in Q3 2021. 285 funds tracked by Wall St. Rank hold PGNY as of Q3 2024.

  • Xponance reported no remaining Progyny position as of Q3 2024 after selling out during the quarter.
  • Xponance sold 11,314 Progyny shares in Q3 2024, an estimated $324K.
  • Xponance first reported a position in Progyny in Q2 2021 and held it in 13 quarters.
  • Xponance's Progyny position peaked at $558K in Q3 2021.
  • 285 funds tracked by Wall St. Rank held Progyny as of Q3 2024.

Based on Xponance's 13F filing for Q3 2024, filed 12 Nov 2024.